You have full text access to this OnlineOpen article

Microdialysis Studies on the Action of Tolcapone on Pharmacologically-Elevated Extracellular Dopamine Levels in Conscious Rats

  1. Marko Huotari,
  2. Raul Gainetdinov,
  3. Pekka T. Männistö

Article first published online: 25 MAR 2009

DOI: 10.1111/j.1600-0773.1999.tb02014.x

Issue

Pharmacology & Toxicology

Pharmacology & Toxicology

Volume 85, Issue Supplement s1, pages 233–238, September 1999

Additional Information

How to Cite

Huotari, M., Gainetdinov, R. and Männistö, P. T. (1999), Microdialysis Studies on the Action of Tolcapone on Pharmacologically-Elevated Extracellular Dopamine Levels in Conscious Rats. Pharmacology & Toxicology, 85: 233–238. doi: 10.1111/j.1600-0773.1999.tb02014.x

Author Information

  1. Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland

*Author for correspondence: Pekka T. Männistö, University of Kuopio, Department of Pharmacology and Toxicology, P.O. Box 1627, FIN-70211 Kuopio, Finland (fax +358 17 162 424, e-mail pekka.mannisto@uku.fi).

Publication History

  1. Issue published online: 25 MAR 2009
  2. Article first published online: 25 MAR 2009
  3. (Received April 6, 1999; Accepted June 15, 1999)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (624K)

References

  • Andersen, P. H.: The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 1989, 166, 493–504.
  • Arbuthnott, G. W., I. S. Fairbrother & S. P. Butcher: Dopamine release and metabolism in the rat striatum; an analysis by in vivo brain dialysis. Pharmacol. Therap. 1990, 48, 281–293.
  • Baldessarini, R. J.: Drugs and the treatment of psychiatric disorders. In: The pharmacological basis of therapeutics. Eds.: A. G.Gilman, L. S.Goodman, T. W.Rall & F.Murad. MacMillan Press, New York, 1985, pp. 387–445.
  • Cadoni, C., A. Pinna, G. Russi, S. Consolo & G. Dichiara: Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and fos immunohistochemistry. Neuroscience 1995, 65, 1027–1039.
  • Da Prada, M., H. H. Keller, L. Pieri, R. Kettler & W. E. Haefely: The pharmacology of Parkinson's disease: basic aspects and recent advances. Experientia 1984, 40, 1165–1172.
  • Eshleman, A. J., E. Stewart, A. K. Evenson, J. N. Mason, R. D. Blakely, A. Janowsky & K. A. Neve: Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. J. Neurochem. 1997, 69, 1459–1466.
    Direct Link:
  • Fahn, S.: ‘On-off’ phenomenon with levodopa therapy in parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology 1974, 24, 431–441.
  • Gainetdinov, R. R., T. V. Grekhova, T. D. Sotnikova & K. S. Rayevsky: Dopamine D-2 and D-3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats. Eur. J. Pharmacol. 1994, 261, 327–331.
  • Hardie, R. J., S. L. Malcolm, A. J. Lees, G. M. Stern & J. G. Allen: The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations. Brit. J. Clin. Pharmacol. 1986, 22, 429–436.
  • Kaakkola, S. & R. J. Wurtman: Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study. Brain Res. 1992, 587, 241–249.
  • Kaakkola, S. & R. J. Wurtman: Effects of COMT inhibitors and L-dopa with and without carbidopa on extracellular dopamine in the rat striatum. J. Neurochem. 1993, 60, 137–144.
    Direct Link:
  • Kaakkola, S., P. T. Männistö & E. Nissinen: Striatal membrane-bound and soluble catechol-O-methyltransferase after selective neural lesions in the rat. J. Neural Transm. [Gen. Sect.] 1987, 69, 221–228.
  • Karhunen, T., C. Tilgmann, I. Ulmanen & P. Panula: Catechol-O-methyltransferase (COMT) in rat brain: immunoelectron microscopic study with an antiserum against rat recombinant COMT protein. Neurosci. Lett. 1995, 187, 57–60.
  • Kask, A., J. Harro, P. Tuomainen, L. Rägo & P. T. Männistö: Overflow of noradrenaline and dopamine in frontal cortex after [N-(chloroethyl)-N-ethyl-2- bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 355, 267–272.
  • Kehr, W.: 3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat striatum in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 1976, 293, 209–215.
  • Kehr, W.: 3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo. J. Neural Transm. [Gen. Sect.] 1981, 50, 165–178.
  • Kopin, I.: Catecholamine metabolism: basic aspects and clinical significance. Pharmacol. Rev. 1985, 37, 333–364.
  • Kuruma, I., G. Bartholini, R. Tissot & A. Pletscher: Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats. J. Pharm. Pharmacol. 1972, 24, 289–294.
    Direct Link:
  • Lundström, K., J. Tenhunen, C. Tilgmann, T. Karhunen, P. Panula & I. Ulmanen: Cloning, expression and structure of catechol-O-methyltransferase. BBA-Prot. Struct. Mol. Enzymol. 1995, 1251, 1–10.
  • Männistö, P. T., P. Tuomainen & R. K. Tuominen: Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat. Brit. J. Pharmacol. 1992a, 105, 569–574.
  • Männistö, P. T., I. Ulmanen, K. Lundström, J. Taskinen, J. Tenhunen, C. Tilgmann & S. Kaakkola: Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors. Prog. Drug Res. 1992b, 39, 291–350.
  • Messiha, F. S., T. H. Hsu & J. R. Bianchine: Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. J. Clin. Invest. 1972, 51, 452–455.
  • Parry, T. J., T. L. Carter & J. G. McElligott: Physical and chemical considerations in the in vitro calibration of microdialysis probes for biogenic amine neurotransmitters and metabolites. J. Neurosci. Methods 1990, 32, 175–183.
  • Paxinos, G. & C. Watson: The rat brain in stereotaxic coordinates. Academic Press, London, 1982.
  • Reilly, D. K., L. Rivera-Calimlim & D. Van Dyke: Catechol-O-methyltransferase activity: a determinant of levodopa response. Clin. Pharmacol. Therap. 1980, 28, 278–286.
  • Rivera-Calimlim, L., D. Tandon, F. Anderson & R. Joynt: The clinical picture and plasma levodopa metabolite profile of Parkinsonian nonresponders. Treatment with levodopa and decarboxylase inhibitor. Arch. Neurol. 1977, 34, 228–232.
  • Sokoloff, P., M. Andrieux, R. Besancon, C. Pilon, M. P. Martres, B. Giros & J. C. Schwartz: Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur. J. Pharmacol. 1992, 225, 331–337.
  • Svensson, K., S. Hjorth, D. Clark, A. Carlsson, H. Wikström, B. Andersson, D. Sanchez, A. M. Johansson, L. E. Arvidsson & U. Hacksell: (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on auto-receptors. J. Neural Transm. [Gen. Sect.] 1986, 65, 1–27.
  • Törnwall, M. & P. T. Männistö: Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats. Eur. J. Pharmacol. 1993, 250, 77–84.
  • Törnwall, M., P. Tuomainen & P. T. Männistö: Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase. Eur. J. Pharmacol. 1993, 239, 39–45.
  • Törnwall, M., S. Kaakkola, P. Tuomainen, A. Kask & P. T. Männistö: Comparison of two new inhibitors of catechol O-methyltransferase on striatal dopamine metabolism: a microdialysis study in rats. Brit. J. Pharmacol. 1994, 112, 13–18.
  • Trendelenburg, U.: The interaction of transport mechanisms and intracellular enzymes in metabolizing systems. J. Neural Transm. [Suppl.] 1990, 32, 3–18.
  • Tuomainen, P., M. Törnwall & P. T. Männistö: Minor effect of tolcapone, a catechol- O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats. Pharmacology & Toxicology 1996, 78, 392–396.
    Direct Link:
  • Wood, P. I. & C. A. Altar: Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxy-tyramine measurements. Pharmacol. Rev. 1988, 40, 163–187.
Get PDF (624K)